NSF and Gadolinium Contrast Dyes Used in MRA/MRI

In 2006, Dutch NSF researchers first discovered the connection between NSF and the Gadolinium Contrast Dyes used in MRI. Since 2006, other researchers have reinforced the Dutch NSF findings. A Yale University study reported that 95-percent of those with NSF had an MRI that involved a Gadolinium contrast dye two to three months before their symptoms appeared.  In 2007, researchers at Massachusetts General Hospital found that kidney patients who had undergone an MRI with a Gadolinium Contrast Dye were 10 times more likely to develop NSF than patient who had not been exposed to such agents. The MRI-NSF injury lawyers at Parker Waichman LLP are currently evaluating cases where victims have been afflicted with NSF due to their exposure to Gadolinium Contrast Dyes used in MRIs.